Hennessy Advisors Inc. cut its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 71.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,050 shares of the medical research company’s stock after selling 24,700 shares during the […]